Industries > Life Sciences & Healthcare > Health Economics and Outcomes Research Services

Health Economics and Outcomes Research Services

SG Analytics (SGA) helps you evaluate evidence of the value of a new drug or product for reimbursement and healthcare payers using AI/ML tools for crisp and precise solutions.

Blogs | Outlook 2023: The Growing Significance of Data Analytics in the Healthcare Sector

Health Economics Outcomes Research (HEOR) Services

HEOR is conducted to analyze DAILY and positive health outcomes by studying healthcare providers, hospitals, clinics, managed care, and public health promotion activities in different set-ups. SGA started its HEOR services and solutions in 2020. It is one of the most sought-after services from our pharmaceutical clients. Our health economics and outcomes research consultants use ML tools to scrape precise real-world data pertinent to medical research and disease areas and transform a cumbersome process into a much easier, white-labeled customized report. The... Read More
Health economics outcomes research services


Industry Leaders

SGA thrives by its brand promise Lifes Possible and is recognized as the trusted life sciences & healthcare business consulting and services provider company in the U.S.

12+ Languages

Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (U.S. & U.K.) experts (either in-house or partnerships).

Data-Driven Insights

With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.

End-To-End Solutioning

The in-house KOL capability of more than 700, along with in-house capabilities of primary market research, financial research, data analytics, engineering, IT, and ESG research and consulting, helps to present credible competitive information.

Who We Work With


SGA Whitepaper Market Entry in 2023


Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?

Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...

SGA Whitepaper Blue Ocean Strategy


The Blue Ocean Strategy in the Pharmaceutical Industry: What Is the Blue Ocean Strategy About?

Blue ocean refers to a new market that presents low competition, is less crowded, and is open to accommodate new innovations and marketing opportunities....

SGA Healthcare Whitepaper Healthcare Consulting & Analytics


What Happens When You Invest in Healthcare Consulting and Analytics?

Healthcare providers who are struggling with high-volume complex data are feeling the need for assistance with data convergence and management. With...

We strongly believe in equal opportunity for all. Our research team consists of more females than males i.e., 55 % females, and consists of PhDs, M Pharms, D Pharms, Postgraduate in finance, Biotech postgraduates, and MBAs.

Our combined experience of pharmaceuticals, medical devices, life sciences, and med-tech ensures high-quality, white-labelled research coverage.